Biocardia Inc. (BCDA)

Market is closed

Sector: Biological Products, (No Disgnostic Substances)

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on February 17, 2026, 1:23pm based on SEC 13F filings Last update: February 17, 2026, 1:23pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Citadel Investment Group Ken Griffin	94,247	$117,809		0%
2.	Pingora Partners Keith Ohnmeis	3,036	$3,795	+194%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Altman Officer, Director	$1.13	5,000	$5,650.00	273,866	2026-02-04	Filing
Altman Officer, Director	$1.34	300	$402.00	268,866	2026-01-21	Filing
Altman Officer, Director	$1.32	600	$792.00	268,566	2026-01-20	Filing
Altman Officer, Director	$1.30	900	$1,170.00	267,966	2025-12-17	Filing
Altman Officer, Director	$1.37	200	$274.00	267,066	2025-12-16	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Gillis Officer	$2.00	3,257	$6,514.00	8,968	2024-12-20	Filing
Frost Large Shareholder	$0.43	129,802	$55,814.86	1,896,025	2024-01-19	Filing
Altman Officer, Director	$2.31	3,200	$7,379.84	203,200	2020-11-27	Filing
Duckers Officer	$2.01	8,435	$16,954.35	12,088	2020-11-02	Filing
Frost Large Shareholder	$0.13	19,230,769	$2,499,999.97	130,503,835	2016-12-21	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Vanguard Group Inc	135,561	$169,452	0%
2.	Cm Management, Llc	130,000	$162,500	0.14%
3.	Geode Capital Management, Llc	66,003	$82,503	0%
4.	Drw Securities, Llc	57,607	$72,008	0%
5.	Susquehanna International Group, Llp	38,809	$48,511	0%